| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 29/04/2024 | 22:05 | GlobeNewswire Inc. | GeneDx Reports First Quarter 2024 Financial Results and Business Highlights | NASDAQ:WGS | GeneDx Holdings Corporation |
| 23/04/2024 | 14:30 | GlobeNewswire Inc. | GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset | NASDAQ:WGS | GeneDx Holdings Corporation |
| 04/04/2024 | 22:05 | GlobeNewswire Inc. | GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024 | NASDAQ:WGS | GeneDx Holdings Corporation |
| 14/03/2024 | 13:30 | GlobeNewswire Inc. | GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics | NASDAQ:WGS | GeneDx Holdings Corporation |
| 05/03/2024 | 22:33 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:WGS | GeneDx Holdings Corporation |
| 26/02/2024 | 22:05 | GlobeNewswire Inc. | GeneDx to Participate in 44th Annual Cowen Health Care Conference | NASDAQ:WGS | GeneDx Holdings Corporation |
| 23/02/2024 | 22:56 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] | NASDAQ:WGS | GeneDx Holdings Corporation |
| 20/02/2024 | 22:28 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:WGS | GeneDx Holdings Corporation |
| 20/02/2024 | 22:26 | GlobeNewswire Inc. | GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024 | NASDAQ:WGS | GeneDx Holdings Corporation |
| 01/02/2024 | 22:30 | GlobeNewswire Inc. | GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024 | NASDAQ:WGS | GeneDx Holdings Corporation |
| 24/01/2024 | 22:30 | GlobeNewswire Inc. | GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | NASDAQ:WGS | GeneDx Holdings Corporation |
| 08/01/2024 | 14:55 | GlobeNewswire Inc. | GeneDx Announces Preliminary 2023 Financial Results | NASDAQ:WGS | GeneDx Holdings Corporation |
| 01/12/2023 | 14:30 | GlobeNewswire Inc. | GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy | NASDAQ:WGS | GeneDx Holdings Corporation |
| 28/11/2023 | 22:05 | GlobeNewswire Inc. | GeneDx to Participate in 6th Annual Evercore ISI HealthCONx Conference | NASDAQ:WGS | GeneDx Holdings Corporation |
| 17/11/2023 | 22:15 | Edgar (US Regulatory) | Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] | NASDAQ:WGS | GeneDx Holdings Corporation |
| 03/11/2023 | 21:06 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:WGS | GeneDx Holdings Corporation |
| 30/10/2023 | 21:05 | GlobeNewswire Inc. | GeneDx Reports Third Quarter 2023 Financial Results and Business Highlights | NASDAQ:WGS | GeneDx Holdings Corporation |
| 09/10/2023 | 22:05 | GlobeNewswire Inc. | GeneDx to Report Third Quarter 2023 Financial Results on Monday, October 30, 2023 | NASDAQ:WGS | GeneDx Holdings Corporation |
| 11/09/2023 | 14:00 | GlobeNewswire Inc. | GeneDx Announces Evolution of Executive Leadership Team | NASDAQ:WGS | GeneDx Holdings Corporation |
| 06/09/2023 | 14:00 | GlobeNewswire Inc. | GeneDx Announces Industry-Leading Accomplishment of 500,000 Clinical Exomes Sequenced | NASDAQ:WGS | GeneDx Holdings Corporation |
| 21/08/2023 | 13:00 | GlobeNewswire Inc. | GeneDx Announces Data Demonstrating that Whole Exome and Genome Sequencing Report Fewer Variants of Uncertain Significance (VUS) than Multi-Gene Panel Testing Published in Genetics in Medicine | NASDAQ:WGS | GeneDx Holdings Corporation |
| 08/08/2023 | 22:20 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee benefit plans | NASDAQ:WGS | GeneDx Holdings Corporation |
| 08/08/2023 | 22:05 | GlobeNewswire Inc. | GeneDx Reports Second Quarter 2023 Financial Results and Business Highlights | NASDAQ:WGS | GeneDx Holdings Corporation |
| 07/08/2023 | 14:00 | PR Newswire (US) | PacBio and GeneDx Launch Research Collaboration with the University of Washington to Study Long-Read Whole Genome Sequencing for Increased Diagnostic Yield in Neonatal Care | NASDAQ:WGS | GeneDx Holdings Corporation |
| 19/07/2023 | 13:05 | GlobeNewswire Inc. | GeneDx and Prognos Health Announce Strategic Partnership to Help Rare Disease Patients More Rapidly Gain Access to Potential Treatment Options | NASDAQ:WGS | GeneDx Holdings Corporation |
| 18/07/2023 | 22:05 | GlobeNewswire Inc. | GeneDx to Report Second Quarter 2023 Financial Results on Tuesday, August 8, 2023 | NASDAQ:WGS | GeneDx Holdings Corporation |
| 28/06/2023 | 13:00 | GlobeNewswire Inc. | GeneDx to Present New Data on Urine Mitochondrial DNA Testing at the 2023 United Mitochondrial Disease Foundation’s Mitochondrial Medicine Symposium | NASDAQ:WGS | GeneDx Holdings Corporation |
| 26/06/2023 | 22:01 | GlobeNewswire Inc. | GeneDx Announces New Tool to Help Harness Human Pangenome Diversity for Clinical Interpretation of Variants | NASDAQ:WGS | GeneDx Holdings Corporation |
| 21/06/2023 | 22:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:WGS | GeneDx Holdings Corporation |
| 20/06/2023 | 23:17 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:WGS | GeneDx Holdings Corporation |